Interdict Bio
Interdict | Home
San Francisco, United States · $26.5M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- interdictbio.com
- Total Funding
- $26.5M
- Last Round
- $17.5M Series ASep 2025
- Rounds
- 2
About
Developer of small molecule Interdictor therapeutics that inhibit ribosomal protein synthesis to address historically undruggable targets.
Summary
Interdict Bio is a Biotech company based in San Francisco, United States. It has raised $26.5M in total across 2 rounds, most recently a $17.5M Series A round in Sep 2025. Investors include Altitude Life Science Ventures, Mission Bay Capital and Venrock.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/interdict-bio"><img src="https://indexed.vc/api/badge/company/interdict-bio" alt="Interdict Bio on Indexed.vc" width="260" height="76" /></a>